Catalyst Wire Dossier Catalyst Wire Dossier

MabThera

rituximab · Roche
Drug timelines are a Plus or Pro feature.

55 regulatory and trial events tracked for MabThera, covering 2007-02-08 to 2026-08-20. Get the full timeline:

Most recent: EMA Authorised: MabThera (rituximab) — Roche Registration GmbH

See pricing